Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits
Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the most health-benefiting components hidden within food, called bioactive peptides.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 30, 2018 | Debt Financing | €30M | 1 | European Investment Bank | — | Detail |
Jan 1, 2015 | Series Unknown | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Investment Bank | Yes | Debt Financing |
Keiretsu Forum | — | Series Unknown |